Metabolic reprogramming in lung cancer and its clinical implication.

MLA

Huang, Qingqiu, et al. “Metabolic Reprogramming in Lung Cancer and Its Clinical Implication.” Frontiers in Pharmacology, Jan. 2025, pp. 1–14. EBSCOhost, https://doi.org/10.3389/fphar.2024.1516650.

APA

Huang, Q., Fan, L., Gong, M., Ren, J., Chen, C., & Xie, S. (2025). Metabolic reprogramming in lung cancer and its clinical implication. Frontiers in Pharmacology, 1–14. https://doi.org/10.3389/fphar.2024.1516650

Chicago

Huang, Qingqiu, Lisha Fan, Mingjing Gong, Juntong Ren, Chen Chen, and Shenglong Xie. 2025. “Metabolic Reprogramming in Lung Cancer and Its Clinical Implication.” Frontiers in Pharmacology, January, 1–14. doi:10.3389/fphar.2024.1516650.